Oramed Pharmaceuticals Inc.
ORMPNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $175.53M
- P/E (TTM)
- 1.07
- Forward P/E
- 0.52
- Dividend yield
- 6.07%
- 52-week range
- $2.09$5.47
- Volume (live)
- -
- Avg. volume (3M)
- 163.03K
Oramed Pharmaceuticals (ORMP) Stock Price & Financial Analysis
Oramed Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $4.06 - $4.17 |
|---|---|
| 52-Week High | $5.47 |
| 52-Week Low | $2.09 |
| Open | $4.10 |
| Volume (last close) | 115.66K |
| Average Volume (3M) | 163.03K |
| 50-Day MA | $4.63 |
|---|---|
| 200-Day MA | $4.00 |
| 1-Year Change | +73.84% |
| Market Cap | 175.53M |
|---|---|
| Shares Outstanding | 42.50M |
| P/E Ratio (TTM) | 1.07 |
| Forward P/E | 0.52 |
| Price to Book (P/B) | 0.55 |
| EV/EBITDA | 1.54 |
| Annual Dividend | $0.25 |
|---|---|
| Dividend Yield | 6.07% |
| Payout Ratio | 6.33% |
| Last Dividend Ex-Date | Jan 16, 2026 |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Oramed Pharmaceuticals at a Glance
As of the Oct 23, 2026 close, Oramed Pharmaceuticals (ORMP) has a market capitalization of $175.53M. The stock trades at 1.1× trailing earnings and 0.5× forward earnings. Revenue fell 100.0% year over year.
As of its latest reported balance sheet, it holds $15.24M in cash and securities against $733.00K of debt, a net cash position of $14.51M.
Oramed Pharmaceuticals pays dividends totaling $0.25 per share a year, a 6.07% yield at the Oct 23, 2026 close, with a 6% payout ratio.
The share price is up 73.8% over the past year. At $4.13 (the Oct 23, 2026 close) it sits within its 52-week range of $2.09 to $5.47, above its 200-day moving average of $4.00.
Frequently Asked Questions About Oramed Pharmaceuticals
What is the current stock price for ORMP?
As of the Oct 23, 2026 close, ORMP stock trades at $4.13. The 52-week range is $2.09–$5.47, with a day range of $4.06–$4.17.
What is the P/E ratio for ORMP?
As of the Oct 23, 2026 close, Oramed Pharmaceuticals's trailing twelve-month (TTM) P/E ratio is 1.1, meaning investors pay $1.1 for every $1 of annual earnings. The forward P/E is 0.5, reflecting analyst expectations for future earnings. Oramed Pharmaceuticals operates in the Healthcare sector.
Does ORMP pay dividends?
Yes, Oramed Pharmaceuticals pays a 6.07% annual dividend yield as of the Oct 23, 2026 close ($0.25 per share a year). The trailing twelve-month payout ratio is 6.3%. The most recent ex-dividend date was January 16, 2026.
What do analysts recommend for ORMP?
Analyst ratings and recommendations for ORMP are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of ORMP?
As of the Oct 23, 2026 close, Oramed Pharmaceuticals's market capitalization is $175.5M, classifying it as a micro-cap company. Oramed Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.